Infections caused by multidrug-resistant Pseudomonas aeruginosa are considered a major public health problem. Antibiotic options are scarce but new drugs are emerging and more maybe available in the near future.
- Pseudomonas aeruginosa as an important pathogen capable of developing resistance to multiple antibiotics
- Common mechanisms of resistance in Pseudomonas aeruginosa
- The current and future approaches for these MDR organisms.
- Michael Satlin, MD, Associate Professor of Medicine, Pathology and Laboratory Medicine, William Randolph Hearst Foundation Clinical Scholar in Microbiology and Infectious Diseases at Weill Cornell Medical College, New York, NY
- Alessandra Carattoli, PhD, Professor of Microbiology at the Sapienza University of Rome, Italy. Editor, AAC
Visit journals.asm.org/journal/aac to browse issues and/or submit a manuscript.